Nirmal Bang said it sees limited room for a significant cut in income taxes, apart from tweaking the lowest tax slabs.

Shares of Cyient Ltd fell 18.58% after weak Q3 FY25 results and CEO resignation. The DET segment saw a drop in YoY profit, while revenue guidance for FY25 was revised downward. Leadership change and ...

Apple Inc (NASDAQ:AAPL)., with its impressive $3.36 trillion market capitalization, is navigating a complex landscape of opportunities and challenges as it enters 2025. As a prominent player in the ...

Cyient is grappling with multiple challenges, including disappointing Q3 results, a downward revision in FY25 growth guidance, and the CEO's resignation, all of which have dampened investor sentiment.

India's domestic investment announcements exceeded Rs. 37 lakh crore (US$ 428.04 billion) in FY23 and FY24, with over 70% from the private sector in 9M FY25, highlighting strong growth in ...

Indus Towers reported a consolidated net profit of Rs 4,003 crore for the quarter, marking a 159.9 per cent increase from Rs ...

IndiGo Q3 net profit is expected to see a sharp YoY fall due to costs associated with Aircraft on Ground (AoG) which have led to higher aircraft lease rentals, depreciation, and financing expenses.

Dr. Reddy's Laboratories shares fell by 6.2% after the company reported a marginal 2% YoY growth in Q3 FY25 net profit to Rs 1,413 crore. Despite robust revenue growth, Jefferies, Nuvama, and DAM ...

Syngene International revised its revenue expectations due to further delays in the US biotech funding environment during the third quarter.

Dr Reddy’s share prices dropped today as brokerages cut targets due to weak US and India performance. Explore the financial outlook now!

Nuvama slashed its FY25 and 26 EPS estimates by 10.8 per cent and 4.5 per cent, respectively, on lower growth and margins. It suggested a revised target price of Rs 1,660 from Rs 1,700 earlier.